In the race to bring new biologics to market, development teams are constantly balancing speed, quality, and regulatory ...

New offering provides drug developers with flexible and powerful cell line development options for monoclonal antibodies, multi-specific and complex molecules SEATTLE--(BUSINESS WIRE)-- As drug ...

A biopharma company specializing in difficult-to-produce biologics has developed a deep learning model to rapidly predict protein expression using their moss-based production process. The model can ...

Leadgene Biosolutions today announces the expansion of its product portfolio following its strategic integration into Leadgene Biomedical. The expanded portfolio supports both early-stage cell line ...

Client programs using CHOMax follow platform-defined workflows and phase-appropriate practices across the development lifecycle.

Cell line development continues to face technical and operational hurdles in transfection, clone selection, and media optimization. Manual screening, extended culture timelines, and fragmented data ...

Cell line creation is a major success factor in biologics manufacturing. It establishes the basis for product yield, quality, and long-term process stability. However, despite significant ...

Tufts University and the Good Food Institute are salvaging cell lines from failed startups to accelerate scalable cultivated ...

During a cell line development project, Agenus UK used the Amperia platform in combination with BLI and SPR to analyze antibody titers. The study found a good correlation between the platforms and ...